In India’s healthcare industry, artificial intelligence is progressing beyond experimental use cases, with entrepreneurs being assessed more on their integration into hospital systems and real-world therapeutic impact than on their technological innovation.
Industry experts point out that scalable applications that lessen clinical workload, enhance patient access, and blend in seamlessly with current workflows are replacing proof-of-concept solutions. With their quicker adoption and obvious benefits in addressing the nation’s lack of medical specialists, diagnostic AI technologies are becoming the most commercially viable area.
Long-term clinical validation and longer regulatory timescales are necessary for oncology-focused AI systems, notwithstanding their potential for addressing complicated diseases. On the other hand, AI solutions connected to tuberculosis are becoming more popular in public health systems because to their scalability, especially when included into larger diagnostic platforms.
Investors are now giving priority to solutions that show quantifiable results in actual clinical settings, according to Gaurav Singh. “The question is if it works in real workflows, improves access, and lessens the stress on clinicians,” he said.
This shift is also being supported by organizations like Blockchain For Impact, which has committed $50 million to help entrepreneurs from prototype to deployment. The gap between invention and widespread acceptance is being filled in part by such hybrid funding and validation methods.
Source – CNBCTV18
